Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 6/20 | 0.82 |
| ▸ | NQO1 | P15559 | 3/20 | 0.64 |
| ▸ | VKORC1 | Q9BQB6 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | ALB | P02768 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | TOP1 | P11387 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenprocoumon SCHEMBL24500472 | 0.91 | CYP2C9 (1.00) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| Phenprocoumon SCHEMBL29392123 | 0.91 | CYP2C9 (1.00) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| Phenprocoumon SCHEMBL43031 | 0.91 | CYP2C9 (1.00) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| Phenprocoumon SCHEMBL24500477 | 0.91 | CYP2C9 (1.00) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| SCHEMBL7351110 | 0.90 | CYP2C9 (0.87) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| SCHEMBL7406235 | 0.87 | CYP2C9 (0.82) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| SCHEMBL13284806 | 0.86 | CYP2C9 (0.84) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| SCHEMBL8042698 | 0.86 | CYP2C9 (0.86) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| SCHEMBL7353207 | 0.85 | CYP2C9 (0.79) | CYP2C9NQO1VKORC1ALDH1A1ALB | |
| SCHEMBL8868104 | 0.85 | CYP2C9 (0.82) | CYP2C9NQO1VKORC1ALDH1A1ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0682663-B1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | UPJOHN CO (US) | 2001-04-18 | — | — | EP | disclosed |
| US-6169181-B1 | HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY | 2001-01-02 | — | — | US | disclosed |
| US-5852195-A | Pyranone compounds useful to treat retroviral infections | PHARMACIA & UPJOHN COMPANY (US) | 1998-12-22 | — | — | US | disclosed |
| US-5686486-A | 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0758327-A1 | PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 1997-02-19 | — | — | EP | disclosed |
| EP-0682663-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1995030670-A2 | PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-16 | — | — | WO | disclosed |
| WO-1994018188-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | THE UPJOHN COMPANY (US) | 1994-08-18 | — | — | WO | disclosed |